Victory Capital Management
ACHV icon

Victory Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Victory Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-535
Closed -$4K – 2504
2020
Q1 		$4K Buy
+535
New +$5.17K ﹤0.01% 3503
2019
Q4 		– Sell
-70
Closed -$2K – 2630
2019
Q3 		$2K Buy
+70
New +$2.75K ﹤0.01% 3611

Other funds holding ACHV

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Searle & Co Greenwich, Connecticut $445M AUM 41.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

Victory Capital Management's ACHV Position: Q2 2020 in Review

Victory Capital Management sold out of Achieve Life Sciences (ACHV) in Q2 2020, closing a stake of 535 shares — an estimated $4K sold.

Victory Capital Management first reported a position in ACHV in Q3 2019 and held it in 2 quarters. The position peaked at $4K in Q1 2020. 13 funds tracked by Wall St. Rank hold ACHV as of Q2 2020.

  • Victory Capital Management reported no remaining Achieve Life Sciences position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 535 Achieve Life Sciences shares in Q2 2020, an estimated $4K.
  • Victory Capital Management first reported a position in Achieve Life Sciences in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Achieve Life Sciences position peaked at $4K in Q1 2020.
  • 13 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.